EcoDrugPlus

Coagulation Factor Xi

Ensembl ID : ENSOCUG00000007279
Gene Symbol: F11
3 Cross references
216 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSOCUG00000002789
Gene Symbol: F12
2 Cross references
185 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSOCUG00000005508
Gene Symbol: CCDC6
2 Cross references
219 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSOCUG00000021056
Gene Symbol: CSF1R
2 Cross references
206 Possible Orthologues:

Complement C1s

Ensembl ID : ENSOCUG00000014468
Gene Symbol: C1S
3 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSOCUG00000005673
Gene Symbol: C5
3 Cross references
208 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSOCUG00000025701
Gene Symbol: CRHR1
3 Cross references
240 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSOCUG00000002858
Gene Symbol: CDK1
3 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSOCUG00000000998
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSOCUG00000012474
Gene Symbol: CDK4
3 Cross references
213 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSOCUG00000021398
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSOCUG00000011078
Gene Symbol: CDK6
3 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).